Literature DB >> 17262741

Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?

Suhsien Lim1, Bart E Muhs, Stuart G Marcus, Elliot Newman, Russel S Berman, Spiros P Hiotis.   

Abstract

BACKGROUND: Patients who present with stage IV gastric cancer are not commonly managed with surgical resection as effective palliation can usually be accomplished with systemic chemotherapy, endoscopic stenting, or surgical bypass procedures. Given the inherent morbidity and mortality associated with gastrectomy, palliative resection for stage IV gastric cancer should be reserved for ideal surgical candidates who are most likely to benefit from the procedure. The purpose of this study is to review outcomes following resection for stage IV gastric cancer, and to identify criteria predictive of improved outcomes following gastrectomy in this setting.
METHODS: A retrospective review of a prospective GI oncology database was conducted. Sixty-three patients with stage IV gastric cancer managed with surgical resection between 1989 and 2001 were identified. Variables including demographic data, patterns of distant spread (ex: peritoneal, lymphatic, hematogenous), location of tumor, and type of gastrectomy were utilized to conduct survival analyses.
RESULTS: Actuarial survival for all patients at one and 3-year intervals was 52% and 12%, respectively. Improved survival was observed for patients of East Asian race (median survival 20 vs. 12 months, P < 0.05, students t-test) and age less than 60 years (median survival 15 vs. 12 months, P < 0.05). This trend was also illustrated by Kaplan-Meier survival analysis. Other variables including pattern of distant spread, location of tumor, and type of gastrectomy were not associated with a significant difference in survival. Both East Asian race and age less than 60 years were statistically significant predictors of improved survival when assessed by univariate regression analysis. When variables were analyzed in a multivariate regression analysis, Asian race and age <60 both lost their statistical significance as independent predictors of improved survival.
CONCLUSIONS: Long-term survival for patients with stage IV gastric cancer who are managed with surgical resection is achievable. Patient specific variables including East Asian race and age less than 60 years appear to be associated with prolonged survival when assessed by comparison of means, Kaplan-Meier analysis, and univariate regression analysis. However, multivariate regression analysis failed to demonstrate these factors as independent predictors of improved outcome. In conclusion, highly selected acceptable risk surgical candidates with stage IV gastric cancer should be considered for management with surgical resection in clinically appropriate scenarios. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17262741     DOI: 10.1002/jso.20328

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  17 in total

Review 1.  Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Goetz; Karin Jandt; Hubert Scheuerlein; Michael Heise; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-04       Impact factor: 3.445

2.  Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Authors:  Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt
Journal:  Gastric Cancer       Date:  2017-07-24       Impact factor: 7.370

3.  Round ligament metastatic gastric cancer as a finding in an inguinal surgery.

Authors:  Ana Ruiz-Casado; Carlos Miliani; Cristina López; Montserrat López; Teresa Martin; Fernando Pereira
Journal:  Gastrointest Cancer Res       Date:  2012-07

4.  [Current S3 guidelines on surgical treatment of gastric carcinoma].

Authors:  H-J Meyer; A H Hölscher; F Lordick; H Messmann; S Mönig; C Schumacher; M Stahl; H Wilke; M Möhler
Journal:  Chirurg       Date:  2012-01       Impact factor: 0.955

5.  Survival benefit of gastrectomy ± metastasectomy in patients with metastatic gastric cancer receiving chemotherapy.

Authors:  Ki Hwan Kim; Keun-Wook Lee; Sun Kyung Baek; Hye Jung Chang; Yu Jung Kim; Do Joong Park; Jee Hyun Kim; Hyung-Ho Kim; Jong Seok Lee
Journal:  Gastric Cancer       Date:  2011-03-04       Impact factor: 7.370

6.  Metastatic lymph node in gastric cancer; is it a real distant metastasis?

Authors:  Do Hyoung Lim; Hyeong Su Kim; Young Suk Park; Jeeyun Lee; Se Hoon Park; Ho Yeong Lim; Sang Hoon Ji; Min Jae Park; Seong Yoon Yi; Ji Yeong An; Tae Sung Sohn; Jae Hyoung Noh; Jae Moon Bae; Sung Kim; Cheol Keun Park; Won Ki Kang
Journal:  BMC Cancer       Date:  2010-01-29       Impact factor: 4.430

7.  Prognosis of pN3 stage gastric cancer.

Authors:  Jung Ryun Ahn; Minkyu Jung; Chan Kim; Min Hee Hong; Hong Jae Chon; Hye Ryun Kim; Hei-Cheul Jeung; Woo Jin Hyung; Sung Sook Lee; Hyun Cheol Chung; Sung Hoon Noh; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2009-06-30       Impact factor: 4.679

8.  Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases.

Authors:  Masahide Ikeguchi; Kozo Miyatani; Seigo Takaya; Tomoyuki Matsunaga; Youji Fukumoto; Tomohiro Osaki; Hiroaki Saito; Toshiro Wakatsuki
Journal:  Indian J Surg Oncol       Date:  2015-07-01

9.  Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.

Authors:  Claus W Schildberg; Thomas Weidinger; Werner Hohenberger; Axel Wein; Melanie Langheinrich; Markus Neurath; Frank Boxberger
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

10.  Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction.

Authors:  Shuji Hiramoto; Ayako Kikuchi; Hori Tetsuso; Akira Yoshioka; Yasushi Kohigashi; Isseki Maeda
Journal:  Int J Clin Oncol       Date:  2018-07-17       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.